Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2250
Abstract: We compared the efficacy, safety, and costs of hypofractionated radiotherapy (HFRT) and conventional fractionated radiotherapy (CFRT) for the neoadjuvant treatment of esophageal cancer. read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Medical Physics"
DOI: 10.1002/mp.12936
Abstract: Purpose To evaluate how protracted delivery of radiation affects radiobiological properties of hypofractionated radiotherapy. Methods The utilized approach is based on the concept of biologically effective dose (BED). The linear‐quadratic model replete with a protraction… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Clinical Genitourinary Cancer"
DOI: 10.1016/j.clgc.2018.10.003
Abstract: Background Bladder cancer is commonly diagnosed in patients ineligible for radical cystectomy or chemoradiotherapy (chemo‐RT) with cisplatin or fluorouracil with mitomycin. We assessed tolerability, efficacy, and toxicity of hypofractionated radiotherapy with capecitabine in this challenging… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/s41416-018-0281-9
Abstract: BackgroundWe conducted a phase I trial evaluating pembrolizumab+hypofractionated radiotherapy (HFRT) for patients with metastatic cancers.MethodsThere were two strata (12 patients each): (i) NSCLC/melanoma progressing on prior anti-PD-1 therapy, (ii) other cancer types; anti-PD-1-naive. Patients received… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Neurosurgery"
DOI: 10.1093/neuros/nyx115
Abstract: Glioblastoma is the most common primary brain tumor in adults. Standard therapy depends on patient age and performance status but principally involves surgical resection followed by a 6-wk course of radiation therapy given concurrently with… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Case Reports in Oncology"
DOI: 10.1159/000529829
Abstract: Abstract QUAD SHOT is an ultra-hypofractionated radiotherapy (RT) technique that prescribes 14.0–14.8 Gy over 2 days. Although this technique has already gained some status as an effective palliative treatment for inoperable head and neck cancer… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.6593
Abstract: 6593Background: Evidence-based guidelines have endorsed use of hypofractionated whole breast irradiation (WBI), a shorter course regimen delivered over 3-4 weeks instead of conventional WBI over 5-... read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Revista da Associacao Medica Brasileira"
DOI: 10.1590/1806-9282.64.11.1031
Abstract: OBJECTIVE To assess the cosmetic satisfaction of patients diagnosed with breast cancer submitted to the hypofractionated radiotherapy with IMRT (hIMRT) technique and its correlation with dosimetric data of the radiotherapy planning. METHODS The retrospective cohort… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12906
Abstract: Background/Aim: Previous randomized clinical trials have shown that moderate hypofractionation has a non-inferior or even superior efficacy to conventionally fractionated external beam radiation therapy (EBRT) in low and intermediate-risk prostate cancer. We herein aimed to… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of the American Veterinary Medical Association"
DOI: 10.2460/javma.253.1.73
Abstract: OBJECTIVE To compare outcomes of dogs treated surgically for oral, nontonsillar, squamous cell carcinomas (SCCs) and fibrosarcomas (FSAs) with outcomes of dogs treated with a combination of surgery and postoperative radiotherapy; to explore whether postoperative,… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "ecancermedicalscience"
DOI: 10.3332/ecancer.2023.1508
Abstract: The rising cancer incidence and mortality in sub-Saharan Africa (SSA) warrants an increased focus on adopting or developing approaches that can significantly increase access to treatment in the region. One such approach recommended by the… read more here.